FRT vs SMLR · rev $1.28B vs P/E 5.0, rev $56.3M
FRT (FRT) versus Semler Scientific Inc (SMLR) — a side-by-side from cached financials, not a winner call.
FRT (FRT) common stock.
Semler Scientific Inc (SMLR) is a medical devices company listed on NASDAQ.
Latest reported FRT revenue for 2025-12-31 was $1.28B. Net income was $411.1M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. FRT currently screens at market cap $0.
Latest reported SMLR revenue for 2024-12-31 was $56.3M. Net income was $40.9M. SMLR currently screens at market cap $348.3M and trailing P/E 5.0.
FRT currently screens at market cap $0. SMLR currently screens at market cap $348.3M and trailing P/E 5.0.
Not investment advice. Open the FRT and SMLR stock pages for the full models.
Not investment advice.